The researchers then tested the capacity of the modified cells to kill human multiple
myeloma cells in laboratory studies and an animal model.
Not exact matches
The
laboratory is interested
in mechanisms by which interactions between neutrophils and multiple
myeloma cells promote disease progression and chemoresistance.
sorafenib induces
cell death
in human
myeloma cell lines
in a
laboratory environment by preventing a certain kind of protein - level activity, an effect that also was achieved when the
myeloma cells had developed a resistance to